Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Sales | 3,636 | 3,863 | 2,191 | 4,532 | 3,055 |
| Cost of Goods | 3,115 | 3,667 | 2,120 | 3,573 | 2,849 |
| Gross Profit | 521 | 196 | 100 | 959 | 206 |
| Operating Expenses | 9,167 | 7,985 | 6,230 | 7,983 | 6,683 |
| Operating Income | -8,531 | -7,122 | -6,039 | -6,451 | -5,628 |
| Interest Expense | 676 | 2,481 | 1,390 | 1,077 | 887 |
| Other Income | 444 | -172 | 389 | -372 | -298 |
| Pre-tax Income | -8,763 | -9,775 | -7,040 | -7,900 | -6,813 |
| Net Income Continuous | -8,763 | -9,775 | -7,044 | -7,900 | -6,813 |
| Net Income | $-8,763 | $-9,775 | $-7,044 | $-7,900 | $-6,813 |
| EPS Basic Total Ops | -0.51 | -0.98 | -12.27 | -13.77 | -11.86 |
| EPS Basic Continuous Ops | -0.51 | -0.98 | -12.27 | -13.76 | -11.87 |
| EPS Diluted Total Ops | -0.51 | -0.98 | -12.27 | -13.77 | -11.86 |
| EPS Diluted Continuous Ops | -0.51 | -0.98 | -12.27 | -13.76 | -11.87 |
| EBITDA(a) | $-7,429 | $-4,911 | $-4,891 | $-5,418 | $-4,571 |